Using these comorbidity and demographic data available with early data on COVID-19 as a surrogate, using groups that have previously been shown to be associated with high ACE2 levels showing higher infection rates and severity of infection, it is possible that variation in ACE2 levels may alter the course of COVID-19. This evidence concerns the gene ACE2 and COVID-19.